Andrew B Herr, Age 545560 Sarahs Oak Dr, Cincinnati, OH 45248

Andrew Herr Phones & Addresses

5560 Sarahs Oak Dr, Cincinnati, OH 45248 (513) 574-4949 (626) 744-0529

Saint Louis, MO

2386 Del Mar Blvd, Pasadena, CA 91107 (626) 744-0529

Tulsa, OK

Los Angeles, CA

Coralville, IA

5560 Sarahs Oak Dr, Cincinnati, OH 45248 (513) 574-4949

Show more

Work

Company: Historic loveland castle museum - Loveland, OH Jun 2000 Position: Volunteer docent

Education

School / High School: SIT/EIL Ecuador- Quito 2011 Specialities: TESOL Certification

Mentions for Andrew B Herr

Andrew Herr resumes & CV records

Resumes

Andrew Herr Photo 36

Professor

Location:
Cincinnati, OH
Industry:
Biotechnology
Work:
Hoth Therapeutics
Technology Advisory Board Member
University of Cincinnati 2003 - Jul 2014
Ohio Eminent Scholar and Associate Professor
University of Cincinnati Mar 2012 - Jun 2014
Associate Director, Medical Scientist Training Program
Chelexa Biosciences Mar 2012 - Jun 2014
Scientific Founder
Caltech 2000 - 2003
Damon Runyon Research Fellow
Cincinnati Children's Hospital Medical Center 2000 - 2003
Professor
Education:
Washington University In St. Louis 1993 - 1999
Doctorates, Doctor of Philosophy, Molecular Biophysics
Oral Roberts University 1989 - 1993
Bachelors, Bachelor of Arts, Chemistry
Skills:
Protein Chemistry, Biophysics, Molecular Biology, Biochemistry, Immunology, Structural Biology, X Ray Crystallography, Protein Expression, Protein Purification, Antibodies, Translational Research, Fluorescence, Drug Discovery, Molecular Modeling, Surface Plasmon Resonance, Fluorescence Spectroscopy, Analytical Ultracentrifugation, Binding Assays, Thermodynamics, Life Sciences, Molecular Microbiology, Circular Dichroism, Biotechnology, Cell Culture
Languages:
English
French
Andrew Herr Photo 37

Wealth Management Advisor

Location:
600 Prairiegate Ct, Lake Saint Louis, MO
Industry:
Banking
Work:
Everbank Sep 2012 - Sep 2015
World Markets and Brokerage Manager
Evertrade Direct Brokerage Sep 2012 - Sep 2015
Brokerage Specialist
Everbank Wealth Management Sep 2012 - Sep 2015
Wealth Management Advisor
St. John the Baptist School 2005 - 2011
Teacher and Coach
Education:
Dowling College 2014
Master of Business Administration, Masters, Corporate Finance
State University of New York Empire State College 2005 - 2008
Bachelors, Bachelor of Arts
State University of New York Empire State College 1977 - 1981
Bachelors, Bachelor of Arts
Skills:
Analysis, Banking, Finance, Investments, Management, Accounting, Customer Service, Financial Services, Risk Management, Credit Analysis, Credit, Leadership, Portfolio Management, Financial Analysis, Auditing, Loans, Internal Audit, Trading
Certifications:
License 6360820
Series 99
Series 66
Financial Industry Regulatory Authority (Finra), License 6360820
Financial Industry Regulatory Authority (Finra)
Andrew Herr Photo 38

Andrew Herr

Andrew Herr Photo 39

Andrew Herr

Location:
St, Louis, MO
Andrew Herr Photo 40

Andrew Herr

Andrew Herr Photo 41

Andrew Herr - Reston, VA

Work:
Historic Loveland Castle Museum - Loveland, OH Jun 2000 to Nov 2012
Volunteer Docent
J Alexander's - Cincinnati, OH Oct 2011 to Apr 2012
Waiter
Fundacion Protropic Por Todos los Ninos - Quito Jan 2011 to Oct 2011
English Language Teacher
GEM Real Estate Group - Mason, OH Jun 2006 to Sep 2008
Research Assistant
Education:
SIT/EIL Ecuador - Quito 2011 to 2011
TESOL Certification
The Ohio State University - Columbus, OH 2006 to 2010
BA in History

Publications & IP owners

Us Patents

Crystal Structure Of Human Gpvi And Applications Thereof

US Patent:
2010031, Dec 16, 2010
Filed:
Mar 28, 2007
Appl. No.:
12/294581
Inventors:
Andrew B. Herr - Cincinnati OH, US
Katsunori Horii - Hyogo, JP
Assignee:
University of Cincinnati - Cincinnati OH
International Classification:
C40B 30/02
G01N 33/50
G01N 33/53
C07K 14/705
G06G 7/48
US Classification:
506 8, 436 87, 435 78, 530395, 703 11
Abstract:
A crystal comprising the collagen binding domain of human GPVI is provided and defined by structural atomic coordinates. Employing computer modeling based on the crystal structure, including methods for identifying inhibitors of GPVI collagen binding activity, methods for screening libraries of compounds for potential to bind to the GPVI collagen binding domain, and methods of identifying a compound useful for the treatment of a GPVI-mediated disorder, are also provided.

Use Of Zinc Chelators To Inhibit Biofilm Formation

US Patent:
2011018, Aug 4, 2011
Filed:
May 29, 2009
Appl. No.:
12/994921
Inventors:
Andrew B. Herr - Cincinnati OH, US
Deborah Gail Conrady - Cincinnati OH, US
Cristin C. Brescia - Canton OH, US
Stefanie L. Ward - Cincinnati OH, US
Assignee:
UNIVERSITY OF CINCINNATI - Cincinnati OH
International Classification:
A01N 37/12
A01N 43/42
A01N 33/02
A61K 9/00
A61K 31/195
A61K 31/4375
A61K 31/13
A01P 1/00
A61P 31/04
US Classification:
424447, 514566, 514292, 514638, 424 54
Abstract:
A method is provided for inhibiting formation of a biofilm of bacteria, the method including contacting the bacteria with an effective amount of at least one zinc chelator, wherein the bacteria contain at least one zinc adhesion module, whereby formation of the biofilm is inhibited. A method for inhibiting biofilm formation on a device and a topical pharmaceutical composition for the inhibition of biofilm formation are also provided.

Crystal Of Human Glycoprotein Vi Collagen Binding Domain

US Patent:
2012013, May 31, 2012
Filed:
Nov 28, 2011
Appl. No.:
13/304942
Inventors:
Andrew B. Herr - Cincinnati OH, US
Katsunori Horii - Hyogo, JP
International Classification:
C40B 30/04
G06G 7/60
G01N 33/53
US Classification:
506 9, 435 71, 703 11
Abstract:
A crystal comprising the collagen binding domain of human GPVI is provided and defined by structural atomic coordinates. Employing computer modeling based on the crystal structure, including methods for identifying inhibitors of GPVI collagen binding activity, methods for screening libraries of compounds for potential to bind to the GPVI collagen binding domain, and methods of identifying a compound useful for the treatment of a GPVI-mediated disorder, are also provided.

Compounds Useful For Inhibiting Bfl1 And Their Use In Therapy

US Patent:
2022024, Aug 11, 2022
Filed:
Jul 9, 2020
Appl. No.:
17/597515
Inventors:
- Cincinnati OH, US
Andrew Herr - Cincinnati OH, US
Suhas G. Kallapur - Cincinnati OH, US
Jarek Meller - Cincinnati OH, US
Alexander Thorman - Cincinnati OH, US
International Classification:
A61K 31/382
A61K 31/353
A61K 47/69
Abstract:
The disclosure provides compounds of Formula I and their use in methods of modulating an immune response by inhibiting BFL1, and related methods for treating and preventing diseases and disorders characterized by inflammation, especially neutrophil induced inflammation.

Methods Of Attenuating An Immune Response By Inhibition Of Bfl1

US Patent:
2023013, Apr 27, 2023
Filed:
Dec 19, 2022
Appl. No.:
18/083617
Inventors:
- Cincinnati OH, US
Andrew Herr - Cincinnati OH, US
Suhas G. Kallapur - Cincinnati OH, US
Jarek Meller - Cincinnati OH, US
Alexander Thorman - Cincinnati OH, US
Assignee:
CHILDREN'S HOSPITAL MEDICAL CENTER - Cincinnati OH
International Classification:
A61K 31/713
A61K 31/655
A61K 31/7105
C12N 15/113
C07K 16/18
Abstract:
The disclosure provides methods of modulating an immune response by inhibiting BFL1, and related methods for treating and preventing diseases and disorders characterized by inflammation, especially neutrophil induced inflammation.

Suppressing Ige-Mediated Allergy By Desensitization With Monovalent Anti-Fcer1A Monoclonal Antibody

US Patent:
2021037, Dec 2, 2021
Filed:
Sep 20, 2019
Appl. No.:
17/277071
Inventors:
- Cincinnati OH, US
- Kiel, DE
Crystal Potter - Fairfield OH, US
Elizabeth Angerman - Fort Thomas KY, US
Andrew Herr - Cincinnati OH, US
Matthias Peipp - Hamburg, DE
International Classification:
C07K 16/28
A61P 37/08
Abstract:
A monovalent monoclonal antibody is provided, the antibody including one light chain, one heavy chain, and one truncated heavy chain, wherein the truncated heavy chain lacks a variable domain and a CH1 domain and wherein the antibody specifically binds an epitope of FcεRIα. Also provided are methods of desensitizing a subject to an allergen, methods of treating an allergy, and methods of preventing an allergic reaction in a subject having an allergy.

Methods Of Treatment By Inhibition Of Bfl1

US Patent:
2021011, Apr 22, 2021
Filed:
Jan 14, 2019
Appl. No.:
15/733346
Inventors:
- Cincinnati OH, US
Andrew Herr - Cincinnati OH, US
Suhas G. Kallapur - Cincinnati OH, US
Jarek Meller - Cincinnati OH, US
Alexander Thorman - Cincinnati OH, US
International Classification:
A61K 31/713
A61K 31/7105
C12N 15/113
C07K 16/18
Abstract:
The disclosure provides methods of modulating an immune response by inhibiting BFL1, and related methods for treating and preventing diseases and disorders characterized by inflammation, especially neutrophil induced inflammation.

Antimicrobial Compositions Of Aminoglycosidic Antibiotics And Zinc Ion Chelators Specifically Formulated For Enhanced Inhibition Of Bacterial Colonization And Antibacterial Efficacy

US Patent:
2014030, Oct 16, 2014
Filed:
Apr 16, 2014
Appl. No.:
14/254362
Inventors:
Andrew B. HERR - Cincinnati OH, US
Stephan DAVIS - Coral Gables FL, US
Gary YOUNG - Coral Gables FL, US
Assignee:
UNIVERSITY OF CINCINNATI - Cincinnati OH
International Classification:
A01N 25/08
A61K 47/12
A01N 43/16
A61K 31/7036
US Classification:
424404, 514 40
Abstract:
Pharmaceutical compositions comprising an aminoglycosidic antibiotic and at least one zinc-chelating agent in a specified concentration, and methods of inhibiting bacterial colonization, biofilm formation and if treating bacterial infections utilizing the compositions are provided. Topical formulations suitable for wound care, and surface-applicable formulations suitable for medical, industrial and household disinfecting needs are also described.

NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.